PNC Financial Services Group
STLN icon

PNC Financial Services Group’s Starling Oncology STLN Stock Holding History

PNC Financial Services Group’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.95K Hold
625
– – ﹤0.01% 4604
2026
Q2 		$3.39K Buy
625
+10
+2% +$42 ﹤0.01% 4523
2026
Q1 		$1.89K Buy
615
+453
+280% +$1.39K ﹤0.01% 4601
2025
Q4 		$577 Buy
162
+10
+7% +$37 ﹤0.01% 4802
2025
Q3 		$530 Buy
+152
New +$521 ﹤0.01% 4795

Other funds holding STLN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Kingswood Wealth Advisors
Kingswood Wealth Advisors San Diego, California $2.6B AUM 27.46% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
T3 Companies
T3 Companies New York $103M AUM 54.73% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

PNC Financial Services Group's STLN Position: Q3 2026 in Review

PNC Financial Services Group held its Starling Oncology (STLN) position steady in Q3 2026 at 625 shares worth $3.95K. The position accounts for ﹤0.01% of the portfolio, ranked #4604.

PNC Financial Services Group first reported a position in STLN in Q3 2025 and has held it in 5 quarters since. 37 funds tracked by Wall St. Rank hold STLN as of Q3 2026.

  • PNC Financial Services Group held 625 shares of Starling Oncology worth $3.95K as of Q3 2026.
  • PNC Financial Services Group left its Starling Oncology share count unchanged in Q3 2026.
  • Starling Oncology made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4604 holding.
  • PNC Financial Services Group first reported a position in Starling Oncology in Q3 2025 and has held it in 5 quarters since.
  • 37 funds tracked by Wall St. Rank held Starling Oncology as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.